Analgesic effects of Sazetidine-A, a new nicotinic cholinergic drug

Anesthesiology
Giovanni CucchiaroKenneth J Kellar

Abstract

The use of nicotinic agonists for analgesia is limited by their unacceptable side effects. Sazetidine-A is a new partial agonist nicotinic ligand that has very high selectivity for beta2-containing nicotinic acetylcholine receptors. It potently and selectively desensitizes alpha4beta2 nicotinic acetylcholine receptors without measurable effects on alpha3beta4 receptors. The authors investigated the analgesic effects of Sazetidine-A using the formalin model of chronic inflammatory pain. The formalin test was conducted after rats received intraperitoneal saline, Sazetidine-A (0.125, 0.25, 0.5, 1, 2 mg/kg), or subcutaneous epibatidine (2.5-5-10 mug/kg). In other experiments, Sazetidine-A was preceded by naloxone (0.5 mg/kg) or mecamylamine (10 mg). Effects of Sazetidine-A and epibatidine on locomotor were tested in an open field, and seizure activity was measured using the Racine scale. Locus coeruleus neuron extracellular single-unit spontaneous discharge was recorded in anesthetized animals after Sazetidine-A and epibatidine. Higher doses of Sazetidine-A (0.5, 1, or 2 mg/kg) induced analgesia, with pain scores significantly lower than those seen after saline, lower doses of Sazetidine-A, and epibatidine (P < 0.001). Naloxone did...Continue Reading

References

Jun 1, 1992·Journal of Natural Products·T F SpandeJ W Daly
Jan 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·P Whiting, J Lindstrom
Mar 1, 1972·Electroencephalography and Clinical Neurophysiology·R J Racine
Dec 21, 1993·European Journal of Pharmacology·C QianS Ip
Jan 5, 2002·Expert Opinion on Investigational Drugs·M W DeckerJ P Sullivan
Dec 21, 2004·The Journal of Pharmacology and Experimental Therapeutics·Giovanni CucchiaroKathryn G Commons
Aug 27, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Andre L CurtisRita J Valentino
Mar 21, 2007·The Journal of Pharmacology and Experimental Therapeutics·M I DamajB R Martin

❮ Previous
Next ❯

Citations

Sep 21, 2013·Journal of Medicinal Chemistry·Venkata M YenugondaMilton L Brown
Oct 26, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Arik J HoneJ Michael McIntosh
Mar 5, 2010·The Journal of Pharmacology and Experimental Therapeutics·Tanuja BordiaMaryka Quik
May 4, 2010·The Journal of Pharmacology and Experimental Therapeutics·Jill R TurnerJulie A Blendy
Jun 9, 2012·The Journal of Pharmacology and Experimental Therapeutics·Shakir D AlSharariM Imad Damaj
Oct 5, 2011·Pharmacological Reviews·Maryka Quik, Susan Wonnacott
Oct 6, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Jiahui ZhangTerry A Hauser
Aug 17, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Neil E PatersonAfshin Ghavami
Mar 2, 2010·Drug and Alcohol Dependence·Wendy M WalwynChristopher J Evans
Oct 2, 2009·Peptides·Richard J Bodnar
Aug 2, 2015·Biochemical Pharmacology·Alvin V TerryCaterina M Hernandez
Sep 12, 2014·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Domingo Palacios-CeñaCésar Fernández-de-Las-Peñas
Sep 25, 2010·Anesthesiology·Yu ShiDavid O Warner
Aug 24, 2018·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Alvin V Terry, Patrick M Callahan
Mar 15, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Loni A Weggel, Anshul A Pandya
Jul 12, 2021·Journal of Pharmaceutical and Biomedical Analysis·Ana ČikošAdrijana Kubiček
Jun 6, 2014·Journal of Medicinal Chemistry·Li-Fang YuAlan P Kozikowski
Nov 20, 2014·ACS Medicinal Chemistry Letters·Oluseye K OnajoleAlan P Kozikowski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.